Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity<sup>®</sup> 2 mg tablets)
- DOI
- 10.1254/fpj.26041
- Published
- 2026-09-01
- Container
- Folia Pharmacologica Japonica
- Publisher
- Japanese Pharmacological Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1254/fpj.26041,
title = {Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity\<sup\>®\</sup\> 2 mg tablets)},
author = {Satoko Nonaka-Hashida and Hirotoshi Yuasa and Ryosuke Ono and Hiroshi Hirano and Koki Fukuta and Masanori Hizue},
year = {2026},
journal = {Folia Pharmacologica Japonica},
doi = {10.1254/fpj.26041},
url = {https://doi.org/10.1254/fpj.26041}
}RIS
TY - JOUR TI - Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity<sup>®</sup> 2 mg tablets) AU - Satoko Nonaka-Hashida AU - Hirotoshi Yuasa AU - Ryosuke Ono AU - Hiroshi Hirano AU - Koki Fukuta AU - Masanori Hizue PY - 2026 JO - Folia Pharmacologica Japonica DO - 10.1254/fpj.26041 UR - https://doi.org/10.1254/fpj.26041 ER -
APA
Nonaka-Hashida, S., Yuasa, H., Ono, R., Hirano, H., Fukuta, K., & Hizue, M. (2026). Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity<sup>®</sup> 2 mg tablets). Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.26041
Source records
- crossref · retrieved 2026-09-25T09:15:49.031Z